title: Does initial graft function influence the outcome after liver transplantation?
authors.affiliation: Department of Surgery, Virchow Clinic, Humboldt University Berlin, Germany.
authors.forename: A R
authors.initials: AR
authors.lastname: Mueller
authors.forename: K P
authors.initials: KP
authors.lastname: Platz
authors.forename: P
authors.initials: P
authors.lastname: Krause
authors.forename: R
authors.initials: R
authors.lastname: Neuhaus
authors.forename: H
authors.initials: H
authors.lastname: Lobeck
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
mesh_terms: D000208:Acute Disease; D016572:Cyclosporine / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012086:Reoperation; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone